- Home
- IVVD
IVVD
Invivyd Inc.
as of 12-03-2025 1:08pm EST
$2.24
+$0.07
+3.47%
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
Chart Type:
Time Range:
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | NEW HAVEN |
| Market Cap: | 692.7M | IPO Year: | 2021 |
| Target Price: | $8.33 | AVG Volume (30 days): | 11.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.45 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.35 - $3.07 | Next Earning Date: | 11-06-2025 |
| Revenue: | $50,039,000 | Revenue Growth: | 332.71% |
| Revenue Growth (this year): | 103.88% | Revenue Growth (next year): | 171.40% |
AI-Powered IVVD Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 19 hours ago
AI Recommendation
hold
Model Accuracy: 69.81%
69.81%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Invivyd Inc. (IVVD)
MCLAUGHLIN KEVIN F
Buy
Director
IVVD Nov 19, 2025
Avg Cost/Share
$2.50
Shares
50,000
Total Value
$125,000.00
Owned After
50,000
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| MCLAUGHLIN KEVIN F | IVVD | Director | Nov 19, 2025 | Buy | $2.50 | 50,000 | $125,000.00 | 50,000 |
Latest Invivyd Inc. News
IVVD Breaking Stock News: Dive into IVVD Ticker-Specific Updates for Smart Investing
Compare IVVD vs Leading Stocks
See how IVVD stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IVVD Invivyd Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.